NVCT
Nuvectis Pharma, Inc.
Company overview
- Market capitalization
- $678.02M
- Employees
- 12
- Latest publication
- 2026-09-29
About Nuvectis Pharma, Inc.
Nuvectis Pharma, Inc., a clinical-stage biopharmaceutical company, focuses on the development of precision medicines for the treatment of serious conditions of unmet medical need in oncology. The company is developing NXP900, a small molecule drug candidate, which is in Phase 1b clinical trial that inhibits the proto-oncogene c-Src and YES1 kinases for treating solid tumors. The company was formerly known as Centry Pharma, Inc. and changed its name to Nuvectis Pharma, Inc. in July 2021. Nuvectis Pharma, Inc. was incorporated in 2020 and is based in Fort Lee, New Jersey.
Financial statements
Income Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 0USD | 0USD | 0USD | 26,796,000USD | 0USD | 0USD |
| Research Development | 4,106,000USD | 5,086,000USD | 5,774,000USD | 3,613,000USD | 3,680,000USD | 4,496,000USD | 2,819,000USD | 2,943,000USD |
| Selling General Administrative | 2,154,000USD | 2,531,000USD | 2,020,000USD | 2,982,000USD | 1,888,000USD | 1,953,000USD | 1,540,000USD | 1,700,000USD |
| Total Operating Expenses | 6,260,000USD | 7,617,000USD | 7,794,000USD | 6,595,000USD | 5,568,000USD | 6,449,000USD | 4,359,000USD | 4,643,000USD |
| Operating Income | -6,260,000USD | -7,617,000USD | -7,794,000USD | -6,595,000USD | -5,568,000USD | -6,449,000USD | -4,359,000USD | -4,643,000USD |
| Interest Income | 210,000USD | 303,000USD | 332,000USD | 261,000USD | 236,000USD | 201,000USD | 206,000USD | 215,000USD |
| Net Interest Income | 210,000USD | 303,000USD | 332,000USD | 261,000USD | 236,000USD | 201,000USD | 206,000USD | 215,000USD |
| Income Before Tax | -6,050,000USD | -7,314,000USD | -7,462,000USD | -6,334,000USD | -5,332,000USD | -6,248,000USD | -4,153,000USD | -4,428,000USD |
| Net Income | -6,050,000USD | -7,314,000USD | -7,462,000USD | -6,334,000USD | -5,332,000USD | -6,248,000USD | -4,153,000USD | -4,428,000USD |
| Net Income From Continuing Ops | -6,050,000USD | -7,314,000USD | -7,462,000USD | -6,334,000USD | -5,332,000USD | -6,248,000USD | -4,153,000USD | -4,428,000USD |
| Ebitda | -6,050,000USD | -8,210,000USD | -7,462,000USD | -6,334,000USD | -5,332,000USD | -6,248,000USD | -4,153,000USD | -4,428,000USD |
| Total Other Income Expense Net | 210,000USD | 303,000USD | 332,000USD | 261,000USD | 236,000USD | 201,000USD | 206,000USD | 215,000USD |
| Depreciation And Amortization | — | — | 7,794,000USD | — | — | — | 206,000USD | — |
| Ebit | — | — | — | -6,595,000USD | -5,568,000USD | -6,449,000USD | -4,359,000USD | -4,643,000USD |
| Cost Of Revenue | — | — | — | — | — | 13,398,000USD | 4,359,000USD | 4,643,000USD |
| Gross Profit | — | — | — | — | — | 13,398,000USD | -4,359,000USD | -4,643,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Income Yearly
| Metric | FY 20252025-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|
| Total Revenue | 0USD | 0USD | 149,000USD | 0USD | — |
| Research Development | 18,153,000USD | 15,380,000USD | 13,227,000USD | 9,545,000USD | — |
| Selling General Administrative | 9,421,000USD | 7,517,000USD | 6,007,000USD | 3,349,000USD | 24,000USD |
| Total Operating Expenses | 27,574,000USD | 22,897,000USD | 19,234,000USD | 12,894,000USD | 10,000USD |
| Operating Income | -27,574,000USD | -22,897,000USD | -19,234,000USD | -12,894,000USD | -10,000USD |
| Interest Income | 1,132,000USD | 475,000USD | 149,000USD | 4,000USD | — |
| Net Interest Income | 1,132,000USD | 475,000USD | 149,000USD | 4,000USD | — |
| Income Before Tax | -26,442,000USD | -22,260,000USD | -19,085,000USD | -12,890,000USD | -10,000USD |
| Net Income | -26,442,000USD | -22,260,000USD | -18,787,000USD | -12,886,000USD | -10,000USD |
| Net Income From Continuing Ops | -26,442,000USD | -22,334,000USD | -19,234,000USD | -12,890,000USD | — |
| Ebitda | -26,442,000USD | -22,260,000USD | -18,936,000USD | -12,890,000USD | -10,000USD |
| Total Other Income Expense Net | 1,132,000USD | 637,000USD | 149,000USD | 4,000USD | 14,000USD |
| Cost Of Revenue | — | 22,897,000USD | 19,234,000USD | 12,894,000USD | — |
| Gross Profit | — | -22,897,000USD | -19,085,000USD | -12,894,000USD | — |
| Selling And Marketing Expenses | — | 14,000USD | — | — | 9,976USD |
| Income Tax Expense | — | 1,000USD | -298,000USD | -4,000USD | -24USD |
| Ebit | — | -21,897,000USD | -19,234,000USD | -12,894,000USD | -34,000USD |
| Depreciation And Amortization | — | -1,000,000USD | 298,000USD | 4,000USD | 24,000USD |
| Interest Expense | — | — | 149,000USD | 4,000USD | 0USD |
| Net Income Applicable To Common Shares | — | — | -19,085,000USD | -12,890,000USD | -24,000USD |
| Other Operating Expenses | — | — | — | — | 10,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q3 20252025-09-30 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD |
|---|---|---|---|---|---|---|---|---|
| Total Assets | 25,398,000USD | 31,709,000USD | 35,587,000USD | 27,007,000USD | 30,148,000USD | 18,607,000USD | 17,307,000USD | 18,298,000USD |
| Other Current Assets | 268,000USD | 75,000USD | 145,000USD | 214,000USD | 284,000USD | 74,000USD | 138,000USD | 182,000USD |
| Total Liab | 11,178,000USD | 13,296,000USD | 11,577,000USD | 10,135,000USD | 9,194,000USD | 8,894,000USD | 6,316,000USD | 5,770,000USD |
| Total Stockholder Equity | 14,220,000USD | 18,413,000USD | 24,010,000USD | 16,872,000USD | 20,954,000USD | 9,713,000USD | 10,991,000USD | 12,528,000USD |
| Other Current Liab | 6,519,000USD | 7,022,000USD | 5,138,000USD | 5,158,000USD | 6,202,000USD | 6,396,000USD | 4,337,000USD | 3,924,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -105,737,000USD | -99,687,000USD | -92,373,000USD | -84,911,000USD | -78,577,000USD | -73,245,000USD | -66,997,000USD | -62,844,000USD |
| Cash | 25,130,000USD | 31,634,000USD | 35,442,000USD | 26,793,000USD | 29,864,000USD | 18,533,000USD | 17,169,000USD | 18,116,000USD |
| Cash And Short Term Investments | 25,130,000USD | 31,634,000USD | 35,442,000USD | 26,793,000USD | 29,864,000USD | 18,533,000USD | 17,169,000USD | 18,116,000USD |
| Total Current Assets | 25,398,000USD | 31,709,000USD | 35,587,000USD | 27,007,000USD | 30,148,000USD | 18,607,000USD | 17,307,000USD | 18,298,000USD |
| Total Current Liabilities | 11,178,000USD | 13,296,000USD | 11,577,000USD | 10,135,000USD | 9,194,000USD | 8,894,000USD | 6,316,000USD | 5,770,000USD |
| Net Debt | -25,130,000USD | -31,634,000USD | -35,442,000USD | -26,793,000USD | -29,864,000USD | -18,533,000USD | -17,169,000USD | -18,116,000USD |
| Accounts Payable | 4,695,000USD | 6,274,000USD | 6,439,000USD | 4,977,000USD | 2,992,000USD | 2,498,000USD | 2,261,000USD | 1,846,000USD |
| Common Stock Shares Outstanding | 23,414,475shares | 21,812,716shares | 22,719,057shares | 21,366,268shares | 19,937,507shares | 19,495,683shares | 17,230,559shares | 16,900,570shares |
| Non Current Assets Total | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Net Working Capital | 14,220,000USD | 18,413,000USD | 24,010,000USD | 16,872,000USD | 20,954,000USD | 9,713,000USD | 10,991,000USD | 12,528,000USD |
| Unclassified Equity | 119,957,000USD | 118,100,000USD | 116,383,000USD | 101,783,000USD | 99,531,000USD | 82,958,000USD | 77,988,000USD | -18,577,316,000USD |
| Common Stock | — | — | — | — | — | — | — | 18,652,688,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Balance sheet Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Total Assets | 31,709,000USD | 18,607,000USD | 19,185,000USD | 20,405,000USD | 6,657,000USD | 6,657,000USD |
| Other Current Assets | 75,000USD | 74,000USD | 59,000USD | 412,000USD | 91,000USD | 91,000USD |
| Total Liab | 13,296,000USD | 8,894,000USD | 6,984,000USD | 6,186,000USD | 17,665,000USD | 10,000USD |
| Total Stockholder Equity | 18,413,000USD | 9,713,000USD | 12,201,000USD | 14,219,000USD | -11,008,000USD | -10,000USD |
| Other Current Liab | 7,022,000USD | 6,396,000USD | 4,213,000USD | 3,276,000USD | 1,361,000USD | -10,000USD |
| Capital Stock | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Retained Earnings | -99,687,000USD | -73,245,000USD | -54,245,000USD | -31,985,000USD | -12,900,000USD | -10,000USD |
| Cash | 31,634,000USD | 18,533,000USD | 19,126,000USD | 19,993,000USD | 5,742,000USD | 5,742,000USD |
| Cash And Short Term Investments | 31,634,000USD | 18,533,000USD | 19,126,000USD | 19,993,000USD | 5,742,000USD | 5,742,000USD |
| Total Current Assets | 31,709,000USD | 18,607,000USD | 19,185,000USD | 20,405,000USD | 5,833,000USD | 5,833,000USD |
| Total Current Liabilities | 13,296,000USD | 8,894,000USD | 6,984,000USD | 6,186,000USD | 2,419,000USD | 10,000USD |
| Net Debt | -31,634,000USD | -18,533,000USD | -19,126,000USD | -19,993,000USD | -5,742,000USD | — |
| Accounts Payable | 6,274,000USD | 2,498,000USD | 2,771,000USD | 2,910,000USD | 1,058,000USD | 10,000USD |
| Common Stock Shares Outstanding | 21,812,716shares | 17,113,169shares | 15,556,655shares | 12,657,651shares | 12,717,794shares | 12,717,794shares |
| Non Current Assets Total | 0USD | 0USD | 0USD | 0USD | 824,000USD | 824,000USD |
| Non Current Liabilities Total | 0USD | 0USD | 0USD | 2,910,000USD | 15,246,000USD | 10,000USD |
| Net Working Capital | 18,413,000USD | 9,713,000USD | 12,201,000USD | 14,219,000USD | 3,414,000USD | -10,000USD |
| Unclassified Equity | 118,100,000USD | 82,958,000USD | -17,702,378,000USD | 46,204,000USD | 1,892,000USD | — |
| Common Stock | — | — | 17,768,824,000USD | 14,752,403,000USD | — | — |
| Accumulated Other Comprehensive Income | — | — | — | -14,752,403,000USD | 0USD | — |
| Net Tangible Assets | — | — | — | 14,219,000USD | -11,008,000USD | -10USD |
| Unclassified Non Current Liabilities | — | — | — | 2,910,000USD | 14,422,000USD | — |
| Deferred Long Term Liab | — | — | — | — | 824,000USD | — |
| Other Assets | — | — | — | — | 824,000USD | — |
| Non Currrent Assets Other | — | — | — | — | 824,000USD | — |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Quarterly
| Metric | Q1 20262026-03-31 · USD | Q4 20252025-12-31 · USD | Q2 20252025-06-30 · USD | Q1 20252025-03-31 · USD | Q4 20242024-12-31 · USD | Q3 20242024-09-30 · USD | Q2 20242024-06-30 · USD | Q1 20242024-03-31 · USD |
|---|---|---|---|---|---|---|---|---|
| Net Income | -6,050,000USD | -7,314,000USD | -6,334,000USD | -5,332,000USD | -6,248,000USD | -4,153,000USD | -4,428,000USD | -4,171,000USD |
| Stock Based Compensation | -460,000USD | 1,476,000USD | 1,731,000USD | 1,368,000USD | 1,141,000USD | 1,159,000USD | 1,262,000USD | 1,296,000USD |
| Other Non Cash Items | 2,310,000USD | 1,476,000USD | 1,731,000USD | — | — | 2,995,000USD | 1,175,000USD | 2,308,000USD |
| Change In Working Capital | -2,311,000USD | 1,864,000USD | 1,236,000USD | -210,000USD | 2,642,000USD | 590,000USD | 146,000USD | -1,483,000USD |
| Total Cash From Operating Activities | -6,511,000USD | -3,974,000USD | -3,367,000USD | -4,174,000USD | -2,465,000USD | -2,404,000USD | -3,020,000USD | -4,358,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -6,511,000USD | -3,974,000USD | -3,367,000USD | -4,174,000USD | -2,465,000USD | -2,404,000USD | -3,020,000USD | -4,358,000USD |
| Total Cash From Financing Activities | 7,000USD | 166,000USD | 296,000USD | 15,505,000USD | 3,829,000USD | 1,457,000USD | 1,672,000USD | 4,696,000USD |
| Issuance Of Capital Stock | 7,000USD | 248,000USD | 614,000USD | 16,798,000USD | 3,953,000USD | 1,507,000USD | 1,727,000USD | 4,849,000USD |
| Change In Cash | -6,504,000USD | -3,808,000USD | -3,071,000USD | 11,331,000USD | 1,364,000USD | -947,000USD | -1,348,000USD | 338,000USD |
| Begin Period Cash Flow | 31,634,000USD | 35,442,000USD | 29,864,000USD | 18,533,000USD | 17,169,000USD | 18,116,000USD | 19,464,000USD | 19,126,000USD |
| End Period Cash Flow | 25,130,000USD | 31,634,000USD | 26,793,000USD | 29,864,000USD | 18,533,000USD | 17,169,000USD | 18,116,000USD | 19,464,000USD |
| Other Cashflows From Financing Activities | 7,000USD | -82,000USD | -318,000USD | -1,293,000USD | -124,000USD | -50,000USD | -55,000USD | -153,000USD |
| Unclassified Operating Cash Flow | — | -1,476,000USD | -1,731,000USD | — | — | -2,995,000USD | -1,175,000USD | -2,308,000USD |
| Investments | — | — | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Cash flow Yearly
| Metric | FY 20252025-12-31 · USD | FY 20242024-12-31 · USD | FY 20232023-12-31 · USD | FY 20222022-12-31 · USD | FY 20212021-12-31 · USD | FY 20202020-12-31 · USD |
|---|---|---|---|---|---|---|
| Net Income | -26,442,000USD | -19,000,000USD | -22,260,000USD | -19,085,000USD | -12,890,000USD | -10,000USD |
| Stock Based Compensation | 1,351,000USD | 4,858,000USD | 4,705,000USD | 1,707,000USD | 1,892,000USD | — |
| Other Non Cash Items | 4,681,000USD | 4,995,000USD | -139,000USD | -2,433,000USD | 307,000USD | 24,000USD |
| Change In Working Capital | 4,401,000USD | 1,895,000USD | 1,740,000USD | 3,819,000USD | 1,494,000USD | 10,000USD |
| Total Cash From Operating Activities | -16,009,000USD | -12,247,000USD | -15,954,000USD | -13,559,000USD | -9,504,000USD | 24,000USD |
| Capital Expenditures | 0USD | 0USD | 0USD | 0USD | 0USD | 0USD |
| Free Cash Flow | -16,009,000USD | -12,247,000USD | -15,954,000USD | -13,559,000USD | -9,504,000USD | 24,000USD |
| Total Cash From Financing Activities | 29,110,000USD | 11,654,000USD | 15,087,000USD | 27,810,000USD | 15,246,000USD | 15,246,000USD |
| Issuance Of Capital Stock | 31,210,000USD | 12,036,000USD | 4,388,000USD | 31,879,000USD | 15,246,000USD | — |
| Change In Cash | 13,101,000USD | -593,000USD | -867,000USD | 14,251,000USD | 5,742,000USD | 24,000USD |
| Begin Period Cash Flow | 18,533,000USD | 19,126,000USD | 19,993,000USD | 5,742,000USD | 7,214,000USD | — |
| End Period Cash Flow | 31,634,000USD | 18,533,000USD | 19,126,000USD | 19,993,000USD | 5,742,000USD | 24,000USD |
| Other Cashflows From Financing Activities | -2,100,000USD | -382,000USD | 9,798,000USD | -4,069,000USD | 15,246,000USD | -4,069,000USD |
| Investments | — | 0USD | 0USD | 0USD | 0USD | — |
| Unclassified Operating Cash Flow | — | -4,995,000USD | — | 2,433,000USD | — | — |
| Change To Liabilities | — | — | — | 4,140,000USD | 1,585,000USD | 24,000USD |
| Sale Purchase Of Stock | — | — | — | 27,810,000USD | — | — |
| Cash And Cash Equivalents Changes | — | — | — | 14,251,000USD | — | — |
| Unclassified Financing Cash Flow | — | — | — | 4,069,000USD | -15,246,000USD | 19,315,000USD |
| Source | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy | Legacy providerLegacy |
Operating metrics
No operating metrics are currently published for this company.
Revenue breakdown
No revenue breakdown is currently published for this company.
Periods follow company fiscal calendars. Quarterly, annual and year-to-date amounts are shown separately. Missing values are not zero. Data may be delayed, incomplete or corrected; follow the disclosure links to verify figures.